TENET HEALTHCARE CORP
Last 30 daysNo qualifying insider buying. Sales: $5.8M by 2 insiders.
Showing the first 6 of 20 trades on this page.
Director
Common Stock
The filing reports a zero transaction price for this gift. It does not establish the market value of the gift.
Director
2026 May Restricted Stock Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
2026 May Restricted Stock Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
2026 May Restricted Stock Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
2026 May Restricted Stock Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
2026 May Restricted Stock Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
2026 May Restricted Stock Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
2026 May Restricted Stock Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
2026 May Restricted Stock Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
2026 May Restricted Stock Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
2026 May Restricted Stock Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
2026 May Restricted Stock Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
Director
2025 May Restricted Stock Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Common Stock
Director
2025 May Restricted Stock Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Common Stock
Director
Common Stock
Director
2025 May Restricted Stock Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Common Stock
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Director | Common StockGift | 150Gift · no purchase price | Not a purchase | Aug 28Filed Aug 31 · 3d later | SEC filing |
| Director | 2026 May Restricted Stock UnitsGrant or award | Derivative units1,188Award · no purchase price | Non-cash award | May 27Filed May 28 · 1d later | SEC filing |
| Director | 2026 May Restricted Stock UnitsGrant or award | Derivative units1,188Award · no purchase price | Non-cash award | May 27Filed May 28 · 1d later | SEC filing |
| Director | 2026 May Restricted Stock UnitsGrant or award | Derivative units1,188Award · no purchase price | Non-cash award | May 27Filed May 28 · 1d later | SEC filing |
| Director | 2026 May Restricted Stock UnitsGrant or award | Derivative units1,188Award · no purchase price | Non-cash award | May 27Filed May 28 · 1d later | SEC filing |
| Director | 2026 May Restricted Stock UnitsGrant or award | Derivative units1,188Award · no purchase price | Non-cash award | May 27Filed May 28 · 1d later | SEC filing |
| Director | 2026 May Restricted Stock UnitsGrant or award | Derivative units1,188Award · no purchase price | Non-cash award | May 27Filed May 28 · 1d later | SEC filing |
| Director | 2026 May Restricted Stock UnitsGrant or award | Derivative units1,188Award · no purchase price | Non-cash award | May 27Filed May 28 · 1d later | SEC filing |
| Director | 2026 May Restricted Stock UnitsGrant or award | Derivative units1,188Award · no purchase price | Non-cash award | May 27Filed May 28 · 1d later | SEC filing |
| Director | 2026 May Restricted Stock UnitsGrant or award | Derivative units1,188Award · no purchase price | Non-cash award | May 27Filed May 28 · 1d later | SEC filing |
| Director | 2026 May Restricted Stock UnitsGrant or award | Derivative units1,464Award · no purchase price | Non-cash award | May 27Filed May 28 · 1d later | SEC filing |
| Director | 2026 May Restricted Stock UnitsGrant or award | Derivative units1,188Award · no purchase price | Non-cash award | May 27Filed May 28 · 1d later | SEC filing |
| Director | Common StockOption exercise or conversion | 1,333Price not reported | Unavailable | May 22Filed May 26 · 4d later | SEC filing |
| Director | 2025 May Restricted Stock UnitsOption exercise or conversion | Derivative units1,333Exercise / conversion price not reported | Not a separate purchase | May 22Filed May 26 · 4d later | SEC filing |
| Director | Common StockOption exercise or conversion | 1,333Price not reported | Unavailable | May 22Filed May 26 · 4d later | SEC filing |
| Director | 2025 May Restricted Stock UnitsOption exercise or conversion | Derivative units1,333Exercise / conversion price not reported | Not a separate purchase | May 22Filed May 26 · 4d later | SEC filing |
| Director | Common StockOption exercise or conversion | 1,333Price not reported | Unavailable | May 22Filed May 26 · 4d later | SEC filing |
| Director | Common StockDisposition to issuer | 493$173.78 / share | $85.67K | May 22Filed May 26 · 4d later | SEC filing |
| Director | 2025 May Restricted Stock UnitsOption exercise or conversion | Derivative units1,333Exercise / conversion price not reported | Not a separate purchase | May 22Filed May 26 · 4d later | SEC filing |
| Director | Common StockOption exercise or conversion | 1,333Price not reported | Unavailable | May 22Filed May 26 · 4d later | SEC filing |
Showing the latest 20 of 42 trades. Show all 42 trades
Tenet Healthcare Corporation Common Stock (THC) · Stock
The filing reports a sale for a joint account.
Jonathan JacksonReporting House memberTenet Healthcare Corporation Common Stock (THC) · Stock
The filing reports a sale for a spouse.
Jonathan JacksonReporting House memberTenet Healthcare Corporation Common Stock (THC) · Stock
The filing reports a partial sale for a spouse.
Jonathan JacksonReporting House memberTenet Healthcare Corporation Common Stock (THC) · Stock
The filing reports a purchase for a joint account.
Jonathan JacksonReporting House memberTenet Healthcare Corporation Common Stock (THC) · Stock
The filing reports a purchase for a spouse.
Jonathan JacksonReporting House memberNo eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
